ORIGINAL ARTICLE
Clinicopathologic characteristics and resection rates of papillary early gastric cancer removed by endoscopic submucosal dissection
 
More details
Hide details
 
Submission date: 2016-06-30
 
 
Acceptance date: 2016-09-08
 
 
Publication date: 2017-03-13
 
 
Pol J Pathol 2017;68(1):11-15
 
KEYWORDS
TOPICS
ABSTRACT
The aim of this study was to assess the: 1) clinicopathologic features of papillary early gastric cancer (PEGC) (13 cases) compared to tubular early gastric cancer (TEGC) (41 cases); 2) efficiency of endoscopic submucosal dissection (ESD) in treatment of PEGC. From January 2007 to February 2016, a total of 54 consecutive patients with early gastric cancer (EGC) underwent ESD at the Department of Gastroenterology of the Pomeranian Medical University in Poland. The histologic type of carcinoma was assessed according to the WHO histological classification of GC. The extension of GC into the submucosa was measured using the Aperio Scan Scope image analysis system tools. PEGCs were diagnosed in 24.1% of the cases of EGC. PEGCs were significantly more elevated in macroscopic examination and better demarcated tumors than TEGC. There were no significant differences between gender, tumor location, ulceration, tumor size, depth of invasion (T), presence of intestinal metaplasia and lymphocytic infiltrate. Curative resection was achieved in 87.1% of patients with EGCs treated with ESD. The lower rate of curative resection (R0) observed in PEGC (76.9%) vs TEGC (90.2%) was not statistically significant. Further studies will be necessary to confirm the clinical and morphological presentation of PEGCs.
REFERENCES (21)
1.
Bosman FT, Carneiro F, Hruban RH, et al. WHO Classification of Tumors of the Digestive System. IARC, Lyon 2010.
 
2.
Tan D, Lauwers GY. Advances in surgical pathology: Gastric cancer. Lippincott Williams and Wilkins, Philadelphia, 2010.
 
3.
Lee HJ, Kim GH, Park do Y, el al. Is endoscopic submucosal dissection safe for papillary adenocarcinoma of the stomach? World J Gastroenterol 2015; 21: 3944-3952.
 
4.
Herreros de Tejada A. ESD training: A challenging path to excellence. World J Gastrointest Endosc 2014; 6: 112-120.
 
5.
Espinel J, Pinedo E, Ojeda V, et al. Treatment modalities for early gastric cancer. World J Gastrointest Endosc 2015; 7: 1062-1069.
 
6.
Bollschweiler E, Berlth F, Baltin Ch, et al. Treatment of early gastric cancer in the Western World. World J Gastroenterol 2014; 20: 5672-5678.
 
7.
Othman MO, Wallace MB. Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) in 2011, a Western perspective. Clin Res Hepatol Gastroenterol 2011; 35: 288-294.
 
8.
Takizawa K, Ono H, Kakushima N, et al. Risk of lymph node metastases from intramucosal gastric cancer in relation to histological types: how to manage the mixed histological type for endoscopic submucosal dissection. Gastric Cancer 2013; 16: 531-536.
 
9.
Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal – type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
 
10.
Kodama Y, Inokuchi K, Soejima K, et al. Growth patterns and prognosis in early gastric carcinoma. Superficially spreading and penetrating growth types. Cancer 1983; 51: 320-326.
 
11.
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010. Gastric Cancer 2011; 14: 113-123.
 
12.
Endoscopic Classification Review Group. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 2005; 37: 570-578.
 
13.
Rhodes TD, Harris JE. TNM Classification for Gastric Cancer. Updated Jan 17, 2014. 2011; 35: 288-294.
 
14.
Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011; 14: 101-112.
 
15.
Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T, et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: 829-854.
 
16.
Repici A, Zullo A, Hassan C, et al. Endoscopic submucosal dissection of early gastric neoplastic lesions: a western series. Eur J Gastroenterol Hepatol 2013; 25: 1261-1264.
 
17.
Bia³ek A. Wiechowska-Koz³owska A, Pertkiewicz J, et al. Endoscopic submucosal dissection for the treatment of neoplastic lesions in the gastrointestinal tract. World J Gastroenterol 2013; 19: 1953-1961.
 
18.
Saragoni L, Morgagni P, Gardini A, et al. Early gastric cancer: diagnosis, staging, and clinical impact. Evaluation of 530 patients. New elements for an updated definition and classification. Gastric Cancer 2013; 16: 549-554.
 
19.
Yasuda K, Adachi Y, Shiraishi N, et al. Papillary adenocarcinoma of the stomach. Gastric Cancer 2000; 3: 33-38.
 
20.
Sekiguchi M, Kushima R, Oda I, et al. Clinical significance of a papillary adenocarcinoma component in early gastric cancer: a single-center retrospective analysis of 628 surgically resected early gastric cancers. J Gastroenterol 2015; 50: 424-434.
 
21.
Kanemitsu T, Yao K, Nagahama T, et al. The vessels within epithelial circle (VEC) pattern as visualized by magnifying endoscopy with narrow-band imaging (ME-NBI) is a useful marker for the diagnosis of papillary adenocarcinoma: a case-controlled study. Gastric Cancer 2014; 17: 469-477.
 
eISSN:2084-9869
ISSN:1233-9687
Journals System - logo
Scroll to top